During the past decade, Salt Lake Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Salt Lake Research" #1 sponsor was "AstraZeneca" with 4 trials, followed by "Mannkind Corporation" with 3 trials sponsored, "Abbott" with 2 trials sponsored, "Bavarian Nordic" with 2 trials sponsored and "FemmePharma Global Healthcare, Inc." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Salt Lake Research" #1 collaborator was "PRA Health Sciences" with 3 trials as a collaborator, "Hoosier Cancer Research Network" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Procter and Gamble" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Salt Lake Research" are "Prostate Cancer" (4 trials), "Healthy" (3 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Prostatic Neoplasms" (2 trials) and "Secondary Hypogonadism" (2 trials). Many other conditions were trialed in "Salt Lake Research" in a lesser frequency.

Most popular intervention types in "Salt Lake Research" are "Drug" (29 trials), "Biological" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "AC2993" (4 trials), "Androxal" (2 trials), "40 mg MSB11022" (1 trials) and "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Salt Lake Research" are 16 trials for "All" genders, 10 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Salt Lake Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Salt Lake Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Salt Lake Research, 6 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".